Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

How to Play
Score 0/96 Timer 20:00
Play Game
HintAnswer
Tolcapone class
Procyclidine class
Risperidone class
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Olanzapine class
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
MOA: Preferential affinity for D3 family of receptors
SE: Insomnia when taken late in the day
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
P-kinetics: Start at low dose & gradually increase
Apomorphine class
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
Use: Most effective drug in tx of Tourette's
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Clonazepam class
Tetrabenxine class
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Ropinirole class
Benzotropine class
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
Levodopa class
Carbidopa + levidopa (1:10 or 1:4)
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
HintAnswer
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
Rasagiline class
Orphenadrine class
P-kinetics: Start with a small dose
Trihexyphenidyl class
P-kinetics: Similar to Pramipexole
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Carbamazepine class
MOA: Pure D2 receptor agonist
MOA: Central (brain) anti-cholinergic
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Butyrophenones class
Use: Similar to Pramipexole
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Use: Gold standard in Parkinson's dz - most efficacious treatment
Fluphenzaine class
TCA class
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Riluzole class
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Quetiapine class
Entacapone class
Selegiline class
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
P-kinetics: Given PO. Loses effectiveness over time.
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
Amantadine class
Use: depression associated with Huntington's disease
HintAnswer
Haloperidol class
Bromocriptine class
Biperiden class
MOA: D1 and D2 receptor agonist
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
Carbidopa class
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
SSRI class
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
MOA: D2 receptor agonist (partial D1 agonist)
Pergolide class
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Use: alleviation of chorea if refractory to atypical
Phenothiazine class
Use: prolong ALS survival by months
Clonidine class
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
Use: alleviation of chorea
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
Reserpine class
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
Pramipexole class
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.
Challenge

You Might Also Like...

Extras

Created Oct 8, 2011ReportNominate
Tags:disorder, drug, movement